Abbott Shaves U.S. Pharma Costs With Restructuring
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott plans to eliminate 1,900 positions, mainly within commercial and manufacturing, in a restructuring that will yield pre-tax savings of $200 million.